Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Insulin Market 2018, Forecast to 2023

Publisher Name :
Date: 12-Jun-2018
No. of pages: 133

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

Scope of the Report:

This report focuses on the Insulin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

There are three type of insulin by resource, it is animal insulin, human insulin, insulin analogue. Animal insulin, because of its side effects, the market share of it is less than 10%, and in the future, the market share will be decrease continually. Human insulin has a larger consumption than insulin analogue, but the side effect is bigger than insulin analogue, so the future market will be occupied by insulin analogue. At the same time, the biggest company producing insulin, Novo Nordisk, has developed a new kind insulin recently, so it will also has a market share in the future.

The worldwide market for Insulin is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Novo Nordisk

- Eli Lilly

- Sanofi-Aventis

- Tonghua Dongbao

- Ganlee

- United Laboratory

- Jiangsu Wanbang

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Animal Insulin

- Regular Human Insulin

- Insulin Analogue

Market Segment by Applications, can be divided into

- Short acting

- Intermediate acting

- Long acting

- Pre-mix Insulin

There are 15 Chapters to deeply display the global Insulin market.

Chapter 1, to describe Insulin Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Insulin, with sales, revenue, and price of Insulin, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Insulin, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Insulin market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Insulin sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Insulin Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Insulin Introduction
1.2 Market Analysis by Type
1.2.1 Animal Insulin
1.2.2 Regular Human Insulin
1.2.3 Insulin Analogue
1.3 Market Analysis by Applications
1.3.1 Short acting
1.3.2 Intermediate acting
1.3.3 Long acting
1.3.4 Pre-mix Insulin
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Business Overview
2.1.1.1 Novo Nordisk Description
2.1.1.2 Novo Nordisk Headquarter, Main Business and Finance Overview
2.1.2 Novo Nordisk Insulin Product Introduction
2.1.2.1 Insulin Production Bases, Sales Regions and Major Competitors
2.1.2.2 Insulin Product Information
2.1.3 Novo Nordisk Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Novo Nordisk Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Novo Nordisk Insulin Market Share in 2017
2.2 Eli Lilly
2.2.1 Business Overview
2.2.1.1 Eli Lilly Description
2.2.1.2 Eli Lilly Headquarter, Main Business and Finance Overview
2.2.2 Eli Lilly Insulin Product Introduction
2.2.2.1 Insulin Production Bases, Sales Regions and Major Competitors
2.2.2.2 Insulin Product Information
2.2.3 Eli Lilly Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Eli Lilly Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Eli Lilly Insulin Market Share in 2017
2.3 Sanofi-Aventis
2.3.1 Business Overview
2.3.1.1 Sanofi-Aventis Description
2.3.1.2 Sanofi-Aventis Headquarter, Main Business and Finance Overview
2.3.2 Sanofi-Aventis Insulin Product Introduction
2.3.2.1 Insulin Production Bases, Sales Regions and Major Competitors
2.3.2.2 Insulin Product Information
2.3.3 Sanofi-Aventis Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Sanofi-Aventis Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Sanofi-Aventis Insulin Market Share in 2017
2.4 Tonghua Dongbao
2.4.1 Business Overview
2.4.1.1 Tonghua Dongbao Description
2.4.1.2 Tonghua Dongbao Headquarter, Main Business and Finance Overview
2.4.2 Tonghua Dongbao Insulin Product Introduction
2.4.2.1 Insulin Production Bases, Sales Regions and Major Competitors
2.4.2.2 Insulin Product Information
2.4.3 Tonghua Dongbao Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Tonghua Dongbao Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Tonghua Dongbao Insulin Market Share in 2017
2.5 Ganlee
2.5.1 Business Overview
2.5.1.1 Ganlee Description
2.5.1.2 Ganlee Headquarter, Main Business and Finance Overview
2.5.2 Ganlee Insulin Product Introduction
2.5.2.1 Insulin Production Bases, Sales Regions and Major Competitors
2.5.2.2 Insulin Product Information
2.5.3 Ganlee Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Ganlee Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Ganlee Insulin Market Share in 2017
2.6 United Laboratory
2.6.1 Business Overview
2.6.1.1 United Laboratory Description
2.6.1.2 United Laboratory Headquarter, Main Business and Finance Overview
2.6.2 United Laboratory Insulin Product Introduction
2.6.2.1 Insulin Production Bases, Sales Regions and Major Competitors
2.6.2.2 Insulin Product Information
2.6.3 United Laboratory Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 United Laboratory Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global United Laboratory Insulin Market Share in 2017
2.7 Jiangsu Wanbang
2.7.1 Business Overview
2.7.1.1 Jiangsu Wanbang Description
2.7.1.2 Jiangsu Wanbang Headquarter, Main Business and Finance Overview
2.7.2 Jiangsu Wanbang Insulin Product Introduction
2.7.2.1 Insulin Production Bases, Sales Regions and Major Competitors
2.7.2.2 Insulin Product Information
2.7.3 Jiangsu Wanbang Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Jiangsu Wanbang Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Jiangsu Wanbang Insulin Market Share in 2017
3 Global Insulin Market Competition, by Manufacturer
3.1 Global Insulin Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Insulin Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Insulin Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Insulin Manufacturer Market Share in 2017
3.4.2 Top 5 Insulin Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Insulin Market Analysis by Regions
4.1 Global Insulin Sales, Revenue and Market Share by Regions
4.1.1 Global Insulin Sales by Regions (2013-2018)
4.1.2 Global Insulin Revenue by Regions (2013-2018)
4.2 North America Insulin Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Insulin Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Insulin Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Insulin Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Insulin Sales, Revenue and Growth Rate (2013-2018)
5 North America Insulin by Countries, Type, Application and Manufacturers
5.1 North America Insulin Sales, Revenue and Market Share by Countries
5.1.1 North America Insulin Sales by Countries (2013-2018)
5.1.2 North America Insulin Revenue by Countries (2013-2018)
5.1.3 United States Insulin Sales and Growth Rate (2013-2018)
5.1.4 Canada Insulin Sales and Growth Rate (2013-2018)
5.1.5 Mexico Insulin Sales and Growth Rate (2013-2018)
5.2 North America Insulin Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Insulin Sales by Manufacturers (2016-2017)
5.2.2 North America Insulin Revenue by Manufacturers (2016-2017)
5.3 North America Insulin Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Insulin Sales and Sales Share by Type (2013-2018)
5.3.2 North America Insulin Revenue and Revenue Share by Type (2013-2018)
5.4 North America Insulin Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Insulin Sales and Sales Share by Application (2013-2018)
5.4.2 North America Insulin Revenue and Revenue Share by Application (2013-2018)
6 Europe Insulin by Countries, Type, Application and Manufacturers
6.1 Europe Insulin Sales, Revenue and Market Share by Countries
6.1.1 Europe Insulin Sales by Countries (2013-2018)
6.1.2 Europe Insulin Revenue by Countries (2013-2018)
6.1.3 Germany Insulin Sales and Growth Rate (2013-2018)
6.1.4 UK Insulin Sales and Growth Rate (2013-2018)
6.1.5 France Insulin Sales and Growth Rate (2013-2018)
6.1.6 Russia Insulin Sales and Growth Rate (2013-2018)
6.1.7 Italy Insulin Sales and Growth Rate (2013-2018)
6.2 Europe Insulin Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Insulin Sales by Manufacturers (2016-2017)
6.2.2 Europe Insulin Revenue by Manufacturers (2016-2017)
6.3 Europe Insulin Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Insulin Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Insulin Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Insulin Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Insulin Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Insulin Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Insulin by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Insulin Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Insulin Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Insulin Revenue by Countries (2013-2018)
7.1.3 China Insulin Sales and Growth Rate (2013-2018)
7.1.4 Japan Insulin Sales and Growth Rate (2013-2018)
7.1.5 Korea Insulin Sales and Growth Rate (2013-2018)
7.1.6 India Insulin Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Insulin Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Insulin Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Insulin Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Insulin Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Insulin Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Insulin Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Insulin Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Insulin Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Insulin Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Insulin Revenue and Revenue Share by Application (2013-2018)
8 South America Insulin by Countries, Type, Application and Manufacturers
8.1 South America Insulin Sales, Revenue and Market Share by Countries
8.1.1 South America Insulin Sales by Countries (2013-2018)
8.1.2 South America Insulin Revenue by Countries (2013-2018)
8.1.3 Brazil Insulin Sales and Growth Rate (2013-2018)
8.1.4 Argentina Insulin Sales and Growth Rate (2013-2018)
8.1.5 Colombia Insulin Sales and Growth Rate (2013-2018)
8.2 South America Insulin Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Insulin Sales by Manufacturers (2016-2017)
8.2.2 South America Insulin Revenue by Manufacturers (2016-2017)
8.3 South America Insulin Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Insulin Sales and Sales Share by Type (2013-2018)
8.3.2 South America Insulin Revenue and Revenue Share by Type (2013-2018)
8.4 South America Insulin Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Insulin Sales and Sales Share by Application (2013-2018)
8.4.2 South America Insulin Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Insulin by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Insulin Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Insulin Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Insulin Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Insulin Sales and Growth Rate (2013-2018)
9.1.4 UAE Insulin Sales and Growth Rate (2013-2018)
9.1.5 Egypt Insulin Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Insulin Sales and Growth Rate (2013-2018)
9.1.7 South Africa Insulin Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Insulin Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Insulin Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Insulin Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Insulin Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Insulin Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Insulin Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Insulin Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Insulin Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Insulin Revenue and Revenue Share by Application (2013-2018)
10 Global Insulin Market Segment by Type
10.1 Global Insulin Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Insulin Sales and Market Share by Type (2013-2018)
10.1.2 Global Insulin Revenue and Market Share by Type (2013-2018)
10.2 Animal Insulin Sales Growth and Price
10.2.1 Global Animal Insulin Sales Growth (2013-2018)
10.2.2 Global Animal Insulin Price (2013-2018)
10.3 Regular Human Insulin Sales Growth and Price
10.3.1 Global Regular Human Insulin Sales Growth (2013-2018)
10.3.2 Global Regular Human Insulin Price (2013-2018)
10.4 Insulin Analogue Sales Growth and Price
10.4.1 Global Insulin Analogue Sales Growth (2013-2018)
10.4.2 Global Insulin Analogue Price (2013-2018)
11 Global Insulin Market Segment by Application
11.1 Global Insulin Sales Market Share by Application (2013-2018)
11.2 Short acting Sales Growth (2013-2018)
11.3 Intermediate acting Sales Growth (2013-2018)
11.4 Long acting Sales Growth (2013-2018)
11.5 Pre-mix Insulin Sales Growth (2013-2018)
12 Insulin Market Forecast (2018-2023)
12.1 Global Insulin Sales, Revenue and Growth Rate (2018-2023)
12.2 Insulin Market Forecast by Regions (2018-2023)
12.2.1 North America Insulin Market Forecast (2018-2023)
12.2.2 Europe Insulin Market Forecast (2018-2023)
12.2.3 Asia-Pacific Insulin Market Forecast (2018-2023)
12.2.4 South America Insulin Market Forecast (2018-2023)
12.2.5 Middle East and Africa Insulin Market Forecast (2018-2023)
12.3 Insulin Market Forecast by Type (2018-2023)
12.3.1 Global Insulin Sales Forecast by Type (2018-2023)
12.3.2 Global Insulin Market Share Forecast by Type (2018-2023)
12.4 Insulin Market Forecast by Application (2018-2023)
12.4.1 Global Insulin Sales Forecast by Application (2018-2023)
12.4.2 Global Insulin Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source


List of Tables and Figures

Figure Insulin Picture
Table Product Specifications of Insulin
Figure Global Insulin CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Insulin CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Insulin by Types in 2017
Figure Animal Insulin Picture
Table Major Manufacturers of Animal Insulin
Figure Regular Human Insulin Picture
Table Major Manufacturers of Regular Human Insulin
Figure Insulin Analogue Picture
Table Major Manufacturers of Insulin Analogue
Figure Insulin Sales Market Share by Applications in 2017
Figure Short acting Picture
Figure Intermediate acting Picture
Figure Long acting Picture
Figure Pre-mix Insulin Picture
Figure United States Insulin Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Insulin Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Insulin Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Insulin Revenue (Value) and Growth Rate (2013-2023)
Figure France Insulin Revenue (Value) and Growth Rate (2013-2023)
Figure UK Insulin Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Insulin Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Insulin Revenue (Value) and Growth Rate (2013-2023)
Figure China Insulin Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Insulin Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Insulin Revenue (Value) and Growth Rate (2013-2023)
Figure India Insulin Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Insulin Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Insulin Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Insulin Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Insulin Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Insulin Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Insulin Revenue (Value) and Growth Rate (2013-2023)
Table Novo Nordisk Headquarter, Established, Main Business and Finance Overview (2017)
Table Novo Nordisk Insulin Production Bases, Sales Regions and Major Competitors
Table Novo Nordisk Insulin Product
Table Novo Nordisk Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novo Nordisk Insulin Sales Market Share in 2017
Figure Global Novo Nordisk Insulin Revenue Market Share in 2017
Table Eli Lilly Headquarter, Established, Main Business and Finance Overview (2017)
Table Eli Lilly Insulin Production Bases, Sales Regions and Major Competitors
Table Eli Lilly Insulin Product
Table Eli Lilly Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Eli Lilly Insulin Sales Market Share in 2017
Figure Global Eli Lilly Insulin Revenue Market Share in 2017
Table Sanofi-Aventis Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofi-Aventis Insulin Production Bases, Sales Regions and Major Competitors
Table Sanofi-Aventis Insulin Product
Table Sanofi-Aventis Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofi-Aventis Insulin Sales Market Share in 2017
Figure Global Sanofi-Aventis Insulin Revenue Market Share in 2017
Table Tonghua Dongbao Headquarter, Established, Main Business and Finance Overview (2017)
Table Tonghua Dongbao Insulin Production Bases, Sales Regions and Major Competitors
Table Tonghua Dongbao Insulin Product
Table Tonghua Dongbao Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Tonghua Dongbao Insulin Sales Market Share in 2017
Figure Global Tonghua Dongbao Insulin Revenue Market Share in 2017
Table Ganlee Headquarter, Established, Main Business and Finance Overview (2017)
Table Ganlee Insulin Production Bases, Sales Regions and Major Competitors
Table Ganlee Insulin Product
Table Ganlee Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Ganlee Insulin Sales Market Share in 2017
Figure Global Ganlee Insulin Revenue Market Share in 2017
Table United Laboratory Headquarter, Established, Main Business and Finance Overview (2017)
Table United Laboratory Insulin Production Bases, Sales Regions and Major Competitors
Table United Laboratory Insulin Product
Table United Laboratory Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global United Laboratory Insulin Sales Market Share in 2017
Figure Global United Laboratory Insulin Revenue Market Share in 2017
Table Jiangsu Wanbang Headquarter, Established, Main Business and Finance Overview (2017)
Table Jiangsu Wanbang Insulin Production Bases, Sales Regions and Major Competitors
Table Jiangsu Wanbang Insulin Product
Table Jiangsu Wanbang Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Jiangsu Wanbang Insulin Sales Market Share in 2017
Figure Global Jiangsu Wanbang Insulin Revenue Market Share in 2017
Table Global Insulin Sales by Manufacturer (2016-2017)
Figure Global Insulin Sales Market Share by Manufacturer in 2016
Figure Global Insulin Sales Market Share by Manufacturer in 2017
Table Global Insulin Revenue by Manufacturer (2016-2017)
Figure Global Insulin Revenue Market Share by Manufacturer in 2016
Figure Global Insulin Revenue Market Share by Manufacturer in 2017
Table Global Insulin Price by Manufacturer (2016-2017)
Figure Top 3 Insulin Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Insulin Manufacturer (Revenue) Market Share in 2017
Figure Global Insulin Sales and Growth Rate (2013-2018)
Figure Global Insulin Revenue and Growth Rate (2013-2018)
Table Global Insulin Sales by Regions (2013-2018)
Table Global Insulin Sales Market Share by Regions (2013-2018)
Table Global Insulin Revenue by Regions (2013-2018)
Figure Global Insulin Revenue Market Share by Regions in 2013
Figure Global Insulin Revenue Market Share by Regions in 2017
Figure North America Insulin Sales and Growth Rate (2013-2018)
Figure North America Insulin Revenue and Growth Rate (2013-2018)
Figure Europe Insulin Sales and Growth Rate (2013-2018)
Figure Europe Insulin Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Insulin Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Insulin Revenue and Growth Rate (2013-2018)
Figure South America Insulin Sales and Growth Rate (2013-2018)
Figure South America Insulin Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Insulin Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Insulin Revenue and Growth Rate (2013-2018)
Figure North America Insulin Revenue and Growth Rate (2013-2018)
Table North America Insulin Sales by Countries (2013-2018)
Table North America Insulin Sales Market Share by Countries (2013-2018)
Figure North America Insulin Sales Market Share by Countries in 2013
Figure North America Insulin Sales Market Share by Countries in 2017
Table North America Insulin Revenue by Countries (2013-2018)
Table North America Insulin Revenue Market Share by Countries (2013-2018)
Figure North America Insulin Revenue Market Share by Countries in 2013
Figure North America Insulin Revenue Market Share by Countries in 2017
Figure United States Insulin Sales and Growth Rate (2013-2018)
Figure Canada Insulin Sales and Growth Rate (2013-2018)
Figure Mexico Insulin Sales and Growth Rate (2013-2018)
Table North America Insulin Sales by Manufacturer (2016-2017)
Figure North America Insulin Sales Market Share by Manufacturer in 2016
Figure North America Insulin Sales Market Share by Manufacturer in 2017
Table North America Insulin Revenue by Manufacturer (2016-2017)
Figure North America Insulin Revenue Market Share by Manufacturer in 2016
Figure North America Insulin Revenue Market Share by Manufacturer in 2017
Table North America Insulin Sales by Type (2013-2018)
Table North America Insulin Sales Share by Type (2013-2018)
Table North America Insulin Revenue by Type (2013-2018)
Table North America Insulin Revenue Share by Type (2013-2018)
Table North America Insulin Sales by Application (2013-2018)
Table North America Insulin Sales Share by Application (2013-2018)
Table North America Insulin Revenue by Application (2013-2018)
Table North America Insulin Revenue Share by Application (2013-2018)
Figure Europe Insulin Revenue and Growth Rate (2013-2018)
Table Europe Insulin Sales by Countries (2013-2018)
Table Europe Insulin Sales Market Share by Countries (2013-2018)
Table Europe Insulin Revenue by Countries (2013-2018)
Figure Europe Insulin Revenue Market Share by Countries in 2016
Figure Europe Insulin Revenue Market Share by Countries in 2017
Figure Germany Insulin Sales and Growth Rate (2013-2018)
Figure UK Insulin Sales and Growth Rate (2013-2018)
Figure France Insulin Sales and Growth Rate (2013-2018)
Figure Russia Insulin Sales and Growth Rate (2013-2018)
Figure Italy Insulin Sales and Growth Rate (2013-2018)
Table Europe Insulin Sales by Manufacturer (2016-2017)
Figure Europe Insulin Sales Market Share by Manufacturer in 2016
Figure Europe Insulin Sales Market Share by Manufacturer in 2017
Table Europe Insulin Revenue by Manufacturer (2016-2017)
Figure Europe Insulin Revenue Market Share by Manufacturer in 2016
Figure Europe Insulin Revenue Market Share by Manufacturer in 2017
Table Europe Insulin Sales by Type (2013-2018)
Table Europe Insulin Sales Share by Type (2013-2018)
Table Europe Insulin Revenue by Type (2013-2018)
Table Europe Insulin Revenue Share by Type (2013-2018)
Table Europe Insulin Sales by Application (2013-2018)
Table Europe Insulin Sales Share by Application (2013-2018)
Table Europe Insulin Revenue by Application (2013-2018)
Table Europe Insulin Revenue Share by Application (2013-2018)
Figure Asia-Pacific Insulin Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Insulin Sales by Countries (2013-2018)
Table Asia-Pacific Insulin Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Insulin Sales Market Share by Countries 2017
Table Asia-Pacific Insulin Revenue by Countries (2013-2018)
Figure Asia-Pacific Insulin Revenue Market Share by Countries 2017
Figure China Insulin Sales and Growth Rate (2013-2018)
Figure Japan Insulin Sales and Growth Rate (2013-2018)
Figure Korea Insulin Sales and Growth Rate (2013-2018)
Figure India Insulin Sales and Growth Rate (2013-2018)
Figure Southeast Asia Insulin Sales and Growth Rate (2013-2018)
Table Asia-Pacific Insulin Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Insulin Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Insulin Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Insulin Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Insulin Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Insulin Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Insulin Sales by Type (2013-2018)
Table Asia-Pacific Insulin Sales Share by Type (2013-2018)
Table Asia-Pacific Insulin Revenue by Type (2013-2018)
Table Asia-Pacific Insulin Revenue Share by Type (2013-2018)
Table Asia-Pacific Insulin Sales by Application (2013-2018)
Table Asia-Pacific Insulin Sales Share by Application (2013-2018)
Table Asia-Pacific Insulin Revenue by Application (2013-2018)
Table Asia-Pacific Insulin Revenue Share by Application (2013-2018)
Figure South America Insulin Revenue and Growth Rate (2013-2018)
Table South America Insulin Sales by Countries (2013-2018)
Table South America Insulin Sales Market Share by Countries (2013-2018)
Figure South America Insulin Sales Market Share by Countries in 2017
Table South America Insulin Revenue by Countries (2013-2018)
Table South America Insulin Revenue Market Share by Countries (2013-2018)
Figure South America Insulin Revenue Market Share by Countries in 2017
Figure Brazil Insulin Sales and Growth Rate (2013-2018)
Figure Argentina Insulin Sales and Growth Rate (2013-2018)
Figure Colombia Insulin Sales and Growth Rate (2013-2018)
Table South America Insulin Sales by Manufacturer (2016-2017)
Figure South America Insulin Sales Market Share by Manufacturer in 2016
Figure South America Insulin Sales Market Share by Manufacturer in 2017
Table South America Insulin Revenue by Manufacturer (2016-2017)
Figure South America Insulin Revenue Market Share by Manufacturer in 2016
Figure South America Insulin Revenue Market Share by Manufacturer in 2017
Table South America Insulin Sales by Type (2013-2018)
Table South America Insulin Sales Share by Type (2013-2018)
Table South America Insulin Revenue by Type (2013-2018)
Table South America Insulin Revenue Share by Type (2013-2018)
Table South America Insulin Sales by Application (2013-2018)
Table South America Insulin Sales Share by Application (2013-2018)
Table South America Insulin Revenue by Application (2013-2018)
Table South America Insulin Revenue Share by Application (2013-2018)
Figure Middle East and Africa Insulin Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Insulin Sales by Countries (2013-2018)
Table Middle East and Africa Insulin Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Insulin Sales Market Share by Countries in 2017
Table Middle East and Africa Insulin Revenue by Countries (2013-2018)
Table Middle East and Africa Insulin Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Insulin Revenue Market Share by Countries in 2013
Figure Middle East and Africa Insulin Revenue Market Share by Countries in 2017
Figure Saudi Arabia Insulin Sales and Growth Rate (2013-2018)
Figure UAE Insulin Sales and Growth Rate (2013-2018)
Figure Egypt Insulin Sales and Growth Rate (2013-2018)
Figure Nigeria Insulin Sales and Growth Rate (2013-2018)
Figure South Africa Insulin Sales and Growth Rate (2013-2018)
Table Middle East and Africa Insulin Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Insulin Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Insulin Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Insulin Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Insulin Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Insulin Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Insulin Sales by Type (2013-2018)
Table Middle East and Africa Insulin Sales Share by Type (2013-2018)
Table Middle East and Africa Insulin Revenue by Type (2013-2018)
Table Middle East and Africa Insulin Revenue Share by Type (2013-2018)
Table Middle East and Africa Insulin Sales by Application (2013-2018)
Table Middle East and Africa Insulin Sales Share by Application (2013-2018)
Table Middle East and Africa Insulin Revenue by Application (2013-2018)
Table Middle East and Africa Insulin Revenue Share by Application (2013-2018)
Table Global Insulin Sales by Type (2013-2018)
Table Global Insulin Sales Share by Type (2013-2018)
Table Global Insulin Revenue by Type (2013-2018)
Table Global Insulin Revenue Share by Type (2013-2018)
Figure Global Animal Insulin Sales Growth (2013-2018)
Figure Global Animal Insulin Price (2013-2018)
Figure Global Regular Human Insulin Sales Growth (2013-2018)
Figure Global Regular Human Insulin Price (2013-2018)
Figure Global Insulin Analogue Sales Growth (2013-2018)
Figure Global Insulin Analogue Price (2013-2018)
Table Global Insulin Sales by Application (2013-2018)
Table Global Insulin Sales Share by Application (2013-2018)
Figure Global Short acting Sales Growth (2013-2018)
Figure Global Intermediate acting Sales Growth (2013-2018)
Figure Global Long acting Sales Growth (2013-2018)
Figure Global Pre-mix Insulin Sales Growth (2013-2018)
Figure Global Insulin Sales, Revenue and Growth Rate (2018-2023)
Table Global Insulin Sales Forecast by Regions (2018-2023)
Table Global Insulin Market Share Forecast by Regions (2018-2023)
Figure North America Sales Insulin Market Forecast (2018-2023)
Figure Europe Sales Insulin Market Forecast (2018-2023)
Figure Asia-Pacific Sales Insulin Market Forecast (2018-2023)
Figure South America Sales Insulin Market Forecast (2018-2023)
Figure Middle East and Africa Sales Insulin Market Forecast (2018-2023)
Table Global Insulin Sales Forecast by Type (2018-2023)
Table Global Insulin Market Share Forecast by Type (2018-2023)
Table Global Insulin Sales Forecast by Application (2018-2023)
Table Global Insulin Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Insulin Glargine Market Research Report 2018
    Published: 19-Jun-2018        Price: US 2900 Onwards        Pages: 95
    This report studies the global Insulin Glargine market status and forecast, categorizes the global Insulin Glargine market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with......
  • Global Insulin Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 12-Jun-2018        Price: US 3480 Onwards        Pages: 136
    Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. Scope of the Report: This rep......
  • Global Insulin API Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 12-Jun-2018        Price: US 3480 Onwards        Pages: 131
    Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal i......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Insulin API Market 2018, Forecast to 2023
    Published: 12-Jun-2018        Price: US 4880 Onwards        Pages: 128
    Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal i......
  • Global Liraglutide Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 11-Jun-2018        Price: US 3480 Onwards        Pages: 137
    Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition. ......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Liraglutide Market 2018, Forecast to 2023
    Published: 11-Jun-2018        Price: US 4880 Onwards        Pages: 134
    Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition. ......
  • Global Diabetes Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 06-Jun-2018        Price: US 3480 Onwards        Pages: 149
    Diabetes is a condition that keeps your body from making enough insulin. Insulin is a hormone that's made by an organ called the pancreas. When the body doesn't make enough insulin, sugar builds up in the blood instead of moving to cells and being used for energy. This causes blood sugar to be high. If blood sugar stays high for a long time, it can cause serious health problems - including blindness, kidney damage, heart disease and stroke. That's why it's important to take medicine that helps l......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Diabetes Drugs Market 2018, Forecast to 2023
    Published: 06-Jun-2018        Price: US 4880 Onwards        Pages: 148
    Diabetes is a condition that keeps your body from making enough insulin. Insulin is a hormone that's made by an organ called the pancreas. When the body doesn't make enough insulin, sugar builds up in the blood instead of moving to cells and being used for energy. This causes blood sugar to be high. If blood sugar stays high for a long time, it can cause serious health problems - including blindness, kidney damage, heart disease and stroke. That's why it's important to take medicine that helps l......
  • 2018-2023 Global Insulin Drug and Delivery Technologies Consumption Market Report
    Published: 05-Jun-2018        Price: US 4660 Onwards        Pages: 136
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Insulin Drug and Delivery Technologies market for 2018-2023. Insulin is a protein hormone that is used as a medication to treat high blood glucose. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states. It is also used along......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs